How Investors Think About Inventions

Why capital requires a company

Siert Bruins Siert Bruins is the author of this webpage
How investors look at your invention

If you have an invention, it is natural to focus on the idea itself: the technology, the novelty, the potential impact. Investors look at the same invention through a very different lens — not because they are sceptical, but because capital works differently from research or product development. Before thinking about funding, it helps to understand how investors actually see risk and return — and why an invention on its own is never investable. This page explains the basic logic investors apply in early-stage ventures, and why that logic almost always leads to the same conclusion: a company is needed before capital can play a role.

Most inventors never planned to deal with investors. You work at a university, a research institute, a hospital, or you have been quietly developing something on your own. Your focus is on solving a problem, making something work, or proving that an idea is technically possible. Then, at some point, the question appears: “How do I get funding for this?” That question is usually asked too late — and in the wrong way. Before thinking about money, it helps to understand how investors look at risk, why inventions are perceived as extremely risky, and why capital almost always flows through companies rather than people or ideas. This cluster explains that mindset. Not to turn you into a financier, but to help you avoid misunderstandings that can derail a promising invention before it ever gets a fair chance.

Investors think in terms of risk and return

Investors analyse startups through a risk vs return lens. Remember, any party interested in financing your project or startup will have the idea that more money can be earned by investing in your invention than when their money earns interest in a regular savings account of a bank. In this latter situation the risk is limited but the interest earned will also be limited. So, investors evaluate your team, technology, market potential, competitive advantage, IP position, scalability and probability of exit (an exit is the moment when an investor gets their money back — usually by selling the company, or their shares in it, to another party). Their expected return depends on the risk of the investment, the size of the market and the likelihood of becoming a meaningful part of their portfolio.

Understanding how investors make decisions helps you prepare stronger pitches, negotiate realistic terms and avoid misunderstandings about growth expectations.

Why inventions are inherently high risk

From an investor's perspective, an invention is not risky because it is new or ambitious. It is risky because several unknowns stack on top of each other.

There is first the technical risk. Even if an invention works in the lab or as a prototype, it is often unclear whether it can be developed into a reliable, scalable and affordable product. Many promising ideas fail at this stage, not because they are wrong, but because reality turns out to be more complex than expected.

On top of that comes market risk. Even a technically successful product still has to find customers who are willing to pay for it. Timing, competition, regulation and user behaviour all play a role here. Investors know from experience that technical success does not automatically translate into commercial success.

There is even a third layer, which is increasingly important, and this is regulatory risk. In many domains a working tech and a willing market are not enough: the invention must also comply with complex and evolving rules and standards.

What makes invention-driven projects particularly risky is that these risks do not replace each other — they add up. Technical uncertainty, market uncertainty and regulatory uncertainty often exist at the same time — and they reinforce each other. This is why inventions are structurally high risk from an investors point of view.

Why most inventions fail commercially

Most inventions do not fail because they are bad ideas. They fail because the path from invention to market is longer, slower and more fragile than expected.

Inventors often focus on what makes their idea unique, while investors look for what makes it sustainable: repeatable sales, a clear value proposition (a clear value proposition is a simple explanation of what problem your invention solves, for whom, and why they would choose it over existing alternatives), defensibility and a realistic path to scale. When these elements remain unclear for too long, capital dries up — even if the technology itself is impressive.

Another common reason is that inventions remain isolated. Without a structure that forces decisions about ownership, roles, priorities and funding, progress becomes dependent on individual motivation rather than shared responsibility. From the outside, this looks unpredictable — and unpredictability is something capital avoids.

Understanding these failure patterns is not meant to discourage you. It helps explain why investors are cautious, and why structure often matters as much as ingenuity.

From invention risk to investable structure

In the financial world, high risk means high return, and low risk means low return. Investors who aim for high returns are prepared to accept a greater possibility of losing their money. Of course, even in those cases, investors still look for ways to minimise their risk. That is why any party providing funding — whether a bank, a venture capital firm, or a wealthy individual (a so-called business angel) — wants to know as precisely as possible where their money will be spent and how this fits into the overall plan for the project.

To succeed in securing funding for your invention, business idea or concept, it is can be very helpfull to have a small company in place. This company exists solely to further develop your idea; it is not intended to employ thousands of people. In fact, many such early-stage companies have no employees at all — not even the founder. The purpose of this small business is to shape your project into a clear and manageable entity. it can hold intellectual property, sign contracts, allocate ownership and absorb financial risk. This is why, before valuation, traction or growth even enter the discussion, investors first look for a real legal entity. Without it, there is simply nothing to invest in.

So when you ask yourself “how do I find funding?”, the real question becomes: “how do I find funding for my small startup company?”

Why investors invest in companies, not in people or ideas

For many inventors, this is the most confusing part of the funding journey. You may feel that the idea lives in your head, your lab or your notebook — so why would an investor insist on a company?

The reason is not personal trust or distrust. Investors invest other people's money, or money they are responsible for. They need a legal and organisational entity that can own assets, enter contracts, receive capital and be held accountable. An idea or an informal group of people cannot do that.

A company creates clarity. It defines who owns what, who can decide what, and what happens if things change. From an investor's point of view, this is not bureaucracy but risk management.

This is why even very early-stage projects are expected to move into a company structure before serious funding discussions begin — not because the invention is finished, but because the investment needs a place to land.

Why capital requires a company

Capital always comes with expectations. Investors want to know how money flows in, how it is used, and under which conditions it can flow out again. A company provides the framework in which these questions can be answered.

Within a company, capital can be staged, monitored and linked to progress. Milestones can be agreed upon, shares can be issued, and value can be built over time. None of this is possible when an invention remains an informal project.

Importantly, a company does not only protect investors. It also protects inventors. It separates personal finances from project risk, allows IP to be properly owned or licensed, and creates continuity beyond individual careers or employment contracts.

Seen this way, a company is not a distraction from innovation. It is the structure that allows innovation to survive long enough to reach the market.

About Siert Bruins

Siert Bruins, PhD

Hello! I'm Siert Bruins, a Dutch entrepreneur and founder of Life2Ledger B.V. . Trained as a Medical Biologist, I hold a PhD in Clinical Diagnostics from the University of Groningen and have over two decades of hands-on experience in innovation at the intersection of universities, hospitals and technology-driven companies.

Throughout my career, I have (co)-founded several life science startups and helped researchers, inventors, and early-stage founders transform their ideas into prototypes, patents, partnerships, and funded projects. My work spans medical device development, clinical validation, startup strategy, and technology transfer. I've guided innovations from the initial sketch to licensing agreements and investment negotiations.

Since 2009, I've run the Dutch version of this site. I launched to provide founders worldwide with practical, experience-based guidance on inventions, patents, valuation and raising startup capital. Today, in Life2Ledger, I also focus on blockchain-based data validation for AI in healthcare — Specifically: how can you be sure that your AI is trained and validated on the correct data, and that this data truly comes from the patient and the device you think it does?

I write everything on this website myself, based on real cases, real negotiations and real outcomes. No content farms. No generic AI text. Just practical guidance from someone who has been in the room.

Want to connect? Visit my LinkedIn or follow me on X. Have questions about your startup strategy or patents? Reach out and I'll share practical insights from real-world experience.